ReP USP - Resultado da busca

Artigo de periodico
Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? (2023)
Zanetti, Maria Olívia Barboza; Rodrigues, João Paulo Vilela; Varallo, Fabiana Rossi ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto ; Pereira, Leonardo Régis Leira
Fonte: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Assuntos: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, ADESÃO À MEDICAÇÃO, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Maria Olívia Barboza et al. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance?. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 348-357, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073469. Acesso em: 30 jun. 2024.
APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? Journal of Oncology Pharmacy Practice, 29( 2), 348-357. doi:10.1177/10781552211073469
NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 348-357.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1177/10781552211073469
Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 348-357.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1177/10781552211073469
Artigo de periodico
Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team (2023)
Zanetti, Maria Olívia Barboza; Rodrigues, João Paulo Vilela; Varallo, Fabiana Rossi ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto ; Pereira, Leonardo Régis Leira
Fonte: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Assuntos: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, HOSPITALIZAÇÃO, SERVIÇOS FARMACÊUTICOS, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Maria Olívia Barboza et al. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 375-385, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073797. Acesso em: 30 jun. 2024.
APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, 29( 2), 375-385. doi:10.1177/10781552211073797
NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1177/10781552211073797
Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1177/10781552211073797
Artigo de periodico
Oral mucosa infection by Mycoplasma salivarium in a patient with chronic graft-versus-host disease: a diagnostic challenge (2022)
Bortolotti, Fernanda; Innocentini, Lara Maria ALencar Ramos ; Macedo, Mayra Dorigan de; Ferrari, Tatiane Cristina; Haddad, Simone Kashima ; Covas, Dimas Tadeu ; Ricz, Hilton Marcos Alves ; Simões, Belinda Pinto ; Cunha, Renato Luiz Guerino ; Macedo, Leandro Dorigan de
Fonte: Hematology, Transfusion and Cell Therapy. Unidades: FORP, FMRP
Assuntos: DOENÇA ENXERTO-HOSPEDEIRO, MUCOSA ORAL, MYCOPLASMA, INFECÇÃO DA FERIDA OPERATÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORTOLOTTI, Fernanda et al. Oral mucosa infection by Mycoplasma salivarium in a patient with chronic graft-versus-host disease: a diagnostic challenge. Hematology, Transfusion and Cell Therapy, v. 44, n. 2, p. 259-263, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2020.08.002. Acesso em: 30 jun. 2024.
APA
Bortolotti, F., Innocentini, L. M. A. L. R., Macedo, M. D. de, Ferrari, T. C., Haddad, S. K., Covas, D. T., et al. (2022). Oral mucosa infection by Mycoplasma salivarium in a patient with chronic graft-versus-host disease: a diagnostic challenge. Hematology, Transfusion and Cell Therapy, 44( 2), 259-263. doi:10.1016/j.htct.2020.08.002
NLM
Bortolotti F, Innocentini LMALR, Macedo MD de, Ferrari TC, Haddad SK, Covas DT, Ricz HMA, Simões BP, Cunha RLG, Macedo LD de. Oral mucosa infection by Mycoplasma salivarium in a patient with chronic graft-versus-host disease: a diagnostic challenge [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 2): 259-263.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.htct.2020.08.002
Vancouver
Bortolotti F, Innocentini LMALR, Macedo MD de, Ferrari TC, Haddad SK, Covas DT, Ricz HMA, Simões BP, Cunha RLG, Macedo LD de. Oral mucosa infection by Mycoplasma salivarium in a patient with chronic graft-versus-host disease: a diagnostic challenge [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 2): 259-263.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.htct.2020.08.002
Artigo de periodico
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients (2022)
Jarduli, Luciana Ribeiro; Azevedo, Júlia Teixeira Cottas de; Clave, Emmanuel; Costa, Thalita Cristina de Mello; Arruda, Lucas Coelho Marliére; Fournier, Isabelle; Palma, Patricia Vianna Bonini; Lima, Keli Cristina de; Dias, Juliana Bernardes Elias; Stracieri, Ana Beatriz Pereira Lima; Pieroni, Fabiano; Cunha, Renato Luiz Guerino; Darrigo Júnior, Luiz Guilherme; Grecco, Carlos Eduardo Setanni; Covas, Dimas Tadeu; Pinto, Ana Cristina Silva; De Santis, Gil Cunha; Simões, Belinda Pinto; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine; Farias, Kelen Cristina Ribeiro Malmegrim de
Fonte: Clinical & Translational Immunology. Unidades: FMRP, FCFRP, FM
Assuntos: CÉLULAS-TRONCO, HOMEOSTASE, REGENERAÇÃO (FENÔMENOS BIOLÓGICOS), ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JARDULI, Luciana Ribeiro et al. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, v. 11, n. 4, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1002/cti2.1389. Acesso em: 30 jun. 2024.
APA
Jarduli, L. R., Azevedo, J. T. C. de, Clave, E., Costa, T. C. de M., Arruda, L. C. M., Fournier, I., et al. (2022). Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, 11( 4), 1-16. doi:10.1002/cti2.1389
NLM
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1002/cti2.1389
Vancouver
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1002/cti2.1389
Artigo de periodico
Epidemiology of invasive fungal disease in haematologic patients (2021)
Souza, Luciana; Nouér, Simone A.; Morales, Hugo; Simões, Belinda Pinto ; Solza, Cristiana; Queiroz‐Telles, Flavio; Nucci, Marcio
Fonte: Mycoses. Unidade: FMRP
Assuntos: LEUCEMIA, LEUCEMIA MIELOIDE AGUDA, EPIDEMIOLOGIA, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luciana et al. Epidemiology of invasive fungal disease in haematologic patients. Mycoses, v. 64, n. 3, p. 252-256, 2021Tradução . . Disponível em: https://doi.org/10.1111/myc.13205. Acesso em: 30 jun. 2024.
APA
Souza, L., Nouér, S. A., Morales, H., Simões, B. P., Solza, C., Queiroz‐Telles, F., & Nucci, M. (2021). Epidemiology of invasive fungal disease in haematologic patients. Mycoses, 64( 3), 252-256. doi:10.1111/myc.13205
NLM
Souza L, Nouér SA, Morales H, Simões BP, Solza C, Queiroz‐Telles F, Nucci M. Epidemiology of invasive fungal disease in haematologic patients [Internet]. Mycoses. 2021 ; 64( 3): 252-256.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1111/myc.13205
Vancouver
Souza L, Nouér SA, Morales H, Simões BP, Solza C, Queiroz‐Telles F, Nucci M. Epidemiology of invasive fungal disease in haematologic patients [Internet]. Mycoses. 2021 ; 64( 3): 252-256.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1111/myc.13205
Artigo de periodico
A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? (2021)
Silveira, Douglas Rafaele Almeida; Coelho-Silva, Juan L.; Silva, Wellington Fernandes da; Vallance, Grant; Pereira-Martins, Diego A; Madeira, Maria I. A.; Figueredo-Pontes, Lorena L.; Velloso, Elvira Deolinda Rodrigues Pereira; Simões, Belinda Pinto; Peniket, Andy; Danby, Robert; Rego, Eduardo Magalhães; Vyas, Paresh; Traina, Fabiola; Bendit, Israel; Quek, Lynn; Rocha, Vanderson
Fonte: Leukemia and Lymphoma. Unidades: FMRP, FM
Assuntos: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTES, CÉLULAS-TRONCO, HEMATOPOESE, LEUCEMIA MIELOIDE AGUDA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Douglas Rafaele Almeida et al. A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ?. Leukemia and Lymphoma, v. 62, n. 1, p. 147-157, 2021Tradução . . Disponível em: https://doi.org/10.1080/10428194.2020.1827252. Acesso em: 30 jun. 2024.
APA
Silveira, D. R. A., Coelho-Silva, J. L., Silva, W. F. da, Vallance, G., Pereira-Martins, D. A., Madeira, M. I. A., et al. (2021). A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? Leukemia and Lymphoma, 62( 1), 147-157. doi:10.1080/10428194.2020.1827252
NLM
Silveira DRA, Coelho-Silva JL, Silva WF da, Vallance G, Pereira-Martins DA, Madeira MIA, Figueredo-Pontes LL, Velloso EDRP, Simões BP, Peniket A, Danby R, Rego EM, Vyas P, Traina F, Bendit I, Quek L, Rocha V. A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? [Internet]. Leukemia and Lymphoma. 2021 ; 62( 1): 147-157.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1080/10428194.2020.1827252
Vancouver
Silveira DRA, Coelho-Silva JL, Silva WF da, Vallance G, Pereira-Martins DA, Madeira MIA, Figueredo-Pontes LL, Velloso EDRP, Simões BP, Peniket A, Danby R, Rego EM, Vyas P, Traina F, Bendit I, Quek L, Rocha V. A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? [Internet]. Leukemia and Lymphoma. 2021 ; 62( 1): 147-157.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1080/10428194.2020.1827252
Artigo de periodico
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia (2021)
Ribeiro, Renata Scopim ; Machado Neto, João Agostinho ; Eide, Christopher A. ; Silva, Juan Luiz Coelho da ; Fenerich, Bruna Alves ; Fernandes, Jaqueline Cristina; Scheucher, Priscila Santos ; Stevens, Samantha L. Savage ; Campos, Paula de Melo; Saad, Sara T. Olalla ; Palma, Leonardo de Carvalho ; Pontes, Lorena Lobo de Figueiredo ; Simões, Belinda Pinto ; Rego, Eduardo Magalhães ; Tognon, Cristina E. ; Druker, Brian J. ; Traina, Fabiola
Fonte: Investigational New Drugs. Unidades: ICB, FMRP, FM
Assuntos: FARMACOLOGIA, LEUCEMIA MIELOIDE, INSULINA, ANTINEOPLÁSICOS, PROTEÍNAS QUINASES, CÉLULAS SANGUÍNEAS, PROLIFERAÇÃO CELULAR, APOPTOSE, ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Renata Scopim et al. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Investigational New Drugs, v. 39, n. 3, p. 736-746, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10637-020-01028-8. Acesso em: 30 jun. 2024.
APA
Ribeiro, R. S., Machado Neto, J. A., Eide, C. A., Silva, J. L. C. da, Fenerich, B. A., Fernandes, J. C., et al. (2021). NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Investigational New Drugs, 39( 3), 736-746. doi:10.1007/s10637-020-01028-8
NLM
Ribeiro RS, Machado Neto JA, Eide CA, Silva JLC da, Fenerich BA, Fernandes JC, Scheucher PS, Stevens SLS, Campos P de M, Saad STO, Palma L de C, Pontes LL de F, Simões BP, Rego EM, Tognon CE, Druker BJ, Traina F. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia [Internet]. Investigational New Drugs. 2021 ; 39( 3): 736-746.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1007/s10637-020-01028-8
Vancouver
Ribeiro RS, Machado Neto JA, Eide CA, Silva JLC da, Fenerich BA, Fernandes JC, Scheucher PS, Stevens SLS, Campos P de M, Saad STO, Palma L de C, Pontes LL de F, Simões BP, Rego EM, Tognon CE, Druker BJ, Traina F. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia [Internet]. Investigational New Drugs. 2021 ; 39( 3): 736-746.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1007/s10637-020-01028-8
Artigo de periodico
Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease (2020)
Tozatto-Maio, Karina; Girot, Robert; Ly, Indou Deme ; Silva-Pinto, Ana Cristina; Rocha, Vanderson Geraldo ; Fernandes, Francisco José de Almeida; Diagne, Ibrahima; Benzerara, Yahia ; Dinardo, Carla Luana ; Soler, Júlia Maria Pavan ; Haddad, Simone Kashima ; Araujo, Itauá Leston ; Kenzey, Chantal ; Fonseca, Guilherme Henrique Hencklain; Sandoval, Evandra Strazza Rodrigues ; Volt, Fernanda; Jarduli, Luciana; Ruggeri, Annalisa ; Mariaselvam, Christina ; Gualandro, Sandra Fátima Menosi ; Rafii, Hanadi ; Cappelli, Barbara ; Nogueira, Felipe Melo; Scigliuolo, Graziana Maria; Cunha, Renato Luiz Guerino ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Simões, Belinda Pinto ; Gluckman, Eliane ; Tamouza, Ryad
Fonte: Frontiers in Immunology. Unidades: FMRP, FM, FCFRP, IME
Assuntos: ANEMIA FALCIFORME, REGRESSÃO LOGÍSTICA, R (SOFTWARE ESTATÍSTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO-MAIO, Karina et al. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease. Frontiers in Immunology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.02041. Acesso em: 30 jun. 2024.
APA
Tozatto-Maio, K., Girot, R., Ly, I. D., Silva-Pinto, A. C., Rocha, V. G., Fernandes, F. J. de A., et al. (2020). Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease. Frontiers in Immunology, 11. doi:10.3389/fimmu.2020.02041
NLM
Tozatto-Maio K, Girot R, Ly ID, Silva-Pinto AC, Rocha VG, Fernandes FJ de A, Diagne I, Benzerara Y, Dinardo CL, Soler JMP, Haddad SK, Araujo IL, Kenzey C, Fonseca GHH, Sandoval ESR, Volt F, Jarduli L, Ruggeri A, Mariaselvam C, Gualandro SFM, Rafii H, Cappelli B, Nogueira FM, Scigliuolo GM, Cunha RLG, Farias KCRM de, Simões BP, Gluckman E, Tamouza R. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease [Internet]. Frontiers in Immunology. 2020 ; 11[citado 2024 jun. 30 ] Available from: https://doi.org/10.3389/fimmu.2020.02041
Vancouver
Tozatto-Maio K, Girot R, Ly ID, Silva-Pinto AC, Rocha VG, Fernandes FJ de A, Diagne I, Benzerara Y, Dinardo CL, Soler JMP, Haddad SK, Araujo IL, Kenzey C, Fonseca GHH, Sandoval ESR, Volt F, Jarduli L, Ruggeri A, Mariaselvam C, Gualandro SFM, Rafii H, Cappelli B, Nogueira FM, Scigliuolo GM, Cunha RLG, Farias KCRM de, Simões BP, Gluckman E, Tamouza R. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease [Internet]. Frontiers in Immunology. 2020 ; 11[citado 2024 jun. 30 ] Available from: https://doi.org/10.3389/fimmu.2020.02041
Artigo de periodico
GVHD-derived plasma as a priming strategy of mesenchymal stem cells (2020)
Silva-Carvalho, Amandda Évelin; Rodrigues, Leane Perim; Schiavinato, Josiane Lilian dos Santos ; Alborghetti, Marcos Rodrigo; Bettarello, Gustavo; Simões, Belinda Pinto ; Neves, Francisco de Assis Rocha; Panepucci, Rodrigo Alexandre; Carvalho, Juliana Lott de; Saldanha-Araujo, Felipe
Fonte: Stem Cell Research & Therapy. Unidade: FMRP
Assuntos: CÉLULAS-TRONCO, LINFÓCITOS, DOENÇA ENXERTO-HOSPEDEIRO, ADJUVANTES IMUNOLÓGICOS, IMUNOSSUPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-CARVALHO, Amandda Évelin et al. GVHD-derived plasma as a priming strategy of mesenchymal stem cells. Stem Cell Research & Therapy, v. 11, p. 1-12, 2020Tradução . . Disponível em: https://doi.org/10.1186/s13287-020-01659-x. Acesso em: 30 jun. 2024.
APA
Silva-Carvalho, A. É., Rodrigues, L. P., Schiavinato, J. L. dos S., Alborghetti, M. R., Bettarello, G., Simões, B. P., et al. (2020). GVHD-derived plasma as a priming strategy of mesenchymal stem cells. Stem Cell Research & Therapy, 11, 1-12. doi:10.1186/s13287-020-01659-x
NLM
Silva-Carvalho AÉ, Rodrigues LP, Schiavinato JL dos S, Alborghetti MR, Bettarello G, Simões BP, Neves F de AR, Panepucci RA, Carvalho JL de, Saldanha-Araujo F. GVHD-derived plasma as a priming strategy of mesenchymal stem cells [Internet]. Stem Cell Research & Therapy. 2020 ; 11 1-12.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1186/s13287-020-01659-x
Vancouver
Silva-Carvalho AÉ, Rodrigues LP, Schiavinato JL dos S, Alborghetti MR, Bettarello G, Simões BP, Neves F de AR, Panepucci RA, Carvalho JL de, Saldanha-Araujo F. GVHD-derived plasma as a priming strategy of mesenchymal stem cells [Internet]. Stem Cell Research & Therapy. 2020 ; 11 1-12.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1186/s13287-020-01659-x
Artigo de periodico-carta/editorial
Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience (2020)
De Santis, Gil Cunha; Costa, Thalita Cristina de Mello; Santos, Flávia Leite Souza ; Pinto, Ana Cristina Silva ; Stracieri, Ana B. P. L.; Pieroni, Fabiano; Darrigo Júnior, Luiz Guilherme; Faria, Joana T. B.; Grecco, Carlos E. S.; Moraes, Daniela A.; Dias, Juliana B.; Rodrigues, Maria Carolina de Oliveira ; Covas, Dimas Tadeu ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto
Fonte: British Journal of Haematology. Unidade: FMRP
Assuntos: TRANSFUSÃO DE SANGUE, ANEMIA FALCIFORME, CÉLULAS-TRONCO, ANTICORPOS, GRUPOS SANGUÍNEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE SANTIS, Gil Cunha et al. Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience. British Journal of Haematology. West Sussex: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/bjh.16703. Acesso em: 30 jun. 2024. , 2020
APA
De Santis, G. C., Costa, T. C. de M., Santos, F. L. S., Pinto, A. C. S., Stracieri, A. B. P. L., Pieroni, F., et al. (2020). Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience. British Journal of Haematology. West Sussex: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1111/bjh.16703
NLM
De Santis GC, Costa TC de M, Santos FLS, Pinto ACS, Stracieri ABPL, Pieroni F, Darrigo Júnior LG, Faria JTB, Grecco CES, Moraes DA, Dias JB, Rodrigues MC de O, Covas DT, Cunha RLG, Simões BP. Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience [Internet]. British Journal of Haematology. 2020 ; 190( 5): e295-e297.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1111/bjh.16703
Vancouver
De Santis GC, Costa TC de M, Santos FLS, Pinto ACS, Stracieri ABPL, Pieroni F, Darrigo Júnior LG, Faria JTB, Grecco CES, Moraes DA, Dias JB, Rodrigues MC de O, Covas DT, Cunha RLG, Simões BP. Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience [Internet]. British Journal of Haematology. 2020 ; 190( 5): e295-e297.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1111/bjh.16703
Artigo de periodico
Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients (2020)
Costa-Pereira, Karla R.; Moraes, Daniela Aparecida; Dias, Juliana Bernardes Elias; Garcia, Juliana Tomé; Oliveira-Cardoso, Érika Arantes de ; Zombrilli, Andréia Ferreira; Leopoldo, Vanessa; Costa, Thalita Melo; Simões, Belinda Pinto ; Oliveira, Maria Carolina
Fonte: JCR : Journal of Clinical Rheumatology. Unidades: FMRP, FFCLRP
Assuntos: REUMATOLOGIA, TRANSPLANTES, CÉLULAS-TRONCO, QUALIDADE DE VIDA, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA-PEREIRA, Karla R. et al. Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients. JCR : Journal of Clinical Rheumatology, v. 26, n. 7S, p. S131-S138, 2020Tradução . . Disponível em: https://doi.org/10.1097/RHU.0000000000001117. Acesso em: 30 jun. 2024.
APA
Costa-Pereira, K. R., Moraes, D. A., Dias, J. B. E., Garcia, J. T., Oliveira-Cardoso, É. A. de, Zombrilli, A. F., et al. (2020). Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients. JCR : Journal of Clinical Rheumatology, 26( 7S), S131-S138. doi:10.1097/RHU.0000000000001117
NLM
Costa-Pereira KR, Moraes DA, Dias JBE, Garcia JT, Oliveira-Cardoso ÉA de, Zombrilli AF, Leopoldo V, Costa TM, Simões BP, Oliveira MC. Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients [Internet]. JCR : Journal of Clinical Rheumatology. 2020 ; 26( 7S): S131-S138.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1097/RHU.0000000000001117
Vancouver
Costa-Pereira KR, Moraes DA, Dias JBE, Garcia JT, Oliveira-Cardoso ÉA de, Zombrilli AF, Leopoldo V, Costa TM, Simões BP, Oliveira MC. Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients [Internet]. JCR : Journal of Clinical Rheumatology. 2020 ; 26( 7S): S131-S138.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1097/RHU.0000000000001117
Artigo de periodico
Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia (2020)
Oliveira, Milena Locci de ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Pippa, Leandro Francisco ; Simões, Belinda Pinto ; Lanchote, Vera Lucia
Fonte: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Assuntos: LEUCEMIA MIELOIDE AGUDA, ANTINEOPLÁSICOS, METABÓLITOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Milena Locci de et al. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, v. 191, p. 1-8, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113576. Acesso em: 30 jun. 2024.
APA
Oliveira, M. L. de, Rocha, A., Nardotto, G. H. B., Pippa, L. F., Simões, B. P., & Lanchote, V. L. (2020). Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, 191, 1-8. doi:10.1016/j.jpba.2020.113576
NLM
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576
Vancouver
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576
Artigo de periodico
Autologous hematopoietic stem cell therapy of the subjects with systemic sclerosis: electromyographic results of the masticatory muscles (2020)
Branco, Thamyres; Oliveira, Lígia Franco; Palinkas, Marcelo ; Vasconcelos, Paulo Batista de ; Oliveira, Maria Carolina; Simões, Belinda Pinto ; Regalo, Isabela Hallak ; Siéssere, Selma ; Regalo, Simone Cecilio Hallak
Fonte: Prague Medical Report. Unidades: FORP, FMRP
Assuntos: FORÇA DE MORDIDA, ELETROMIOGRAFIA, CÉLULAS-TRONCO, MÚSCULOS MASTIGATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANCO, Thamyres et al. Autologous hematopoietic stem cell therapy of the subjects with systemic sclerosis: electromyographic results of the masticatory muscles. Prague Medical Report, v. 121, n. 3, p. 163-171, 2020Tradução . . Disponível em: https://doi.org/10.14712/23362936.2020.15. Acesso em: 30 jun. 2024.
APA
Branco, T., Oliveira, L. F., Palinkas, M., Vasconcelos, P. B. de, Oliveira, M. C., Simões, B. P., et al. (2020). Autologous hematopoietic stem cell therapy of the subjects with systemic sclerosis: electromyographic results of the masticatory muscles. Prague Medical Report, 121( 3), 163-171. doi:10.14712/23362936.2020.15
NLM
Branco T, Oliveira LF, Palinkas M, Vasconcelos PB de, Oliveira MC, Simões BP, Regalo IH, Siéssere S, Regalo SCH. Autologous hematopoietic stem cell therapy of the subjects with systemic sclerosis: electromyographic results of the masticatory muscles [Internet]. Prague Medical Report. 2020 ; 121( 3): 163-171.[citado 2024 jun. 30 ] Available from: https://doi.org/10.14712/23362936.2020.15
Vancouver
Branco T, Oliveira LF, Palinkas M, Vasconcelos PB de, Oliveira MC, Simões BP, Regalo IH, Siéssere S, Regalo SCH. Autologous hematopoietic stem cell therapy of the subjects with systemic sclerosis: electromyographic results of the masticatory muscles [Internet]. Prague Medical Report. 2020 ; 121( 3): 163-171.[citado 2024 jun. 30 ] Available from: https://doi.org/10.14712/23362936.2020.15
Artigo de periodico
A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays (2020)
Tognon, Raquel; Silva, Danillo Cunha de Almeida e ; Rey, Rita Andraos; Ristov, Mitko; Ambrósio, Luciana; Almeida, Felipe Campos de ; Nunes, Natália de Souza; Souto, Elizabeth Xisto; Perobelli, Leila de Lourdes; Simões, Belinda Pinto ; Guthy, Daniel Alexander; Radimerski, Thomas; Castro, Fabíola Attié de
Fonte: Leukemia & Lymphoma. Unidades: FMRP, FCFRP, BIOINFORMÁTICA
Assuntos: NEOPLASIAS, MUTAÇÃO GENÉTICA, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOGNON, Raquel et al. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays. Leukemia & Lymphoma, v. 61, n. 13, p. 3052-3065, 2020Tradução . . Disponível em: https://doi.org/10.1080/10428194.2020.1805110. Acesso em: 30 jun. 2024.
APA
Tognon, R., Silva, D. C. de A. e, Rey, R. A., Ristov, M., Ambrósio, L., Almeida, F. C. de, et al. (2020). A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays. Leukemia & Lymphoma, 61( 13), 3052-3065. doi:10.1080/10428194.2020.1805110
NLM
Tognon R, Silva DC de A e, Rey RA, Ristov M, Ambrósio L, Almeida FC de, Nunes N de S, Souto EX, Perobelli L de L, Simões BP, Guthy DA, Radimerski T, Castro FA de. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays [Internet]. Leukemia & Lymphoma. 2020 ; 61( 13): 3052-3065.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1080/10428194.2020.1805110
Vancouver
Tognon R, Silva DC de A e, Rey RA, Ristov M, Ambrósio L, Almeida FC de, Nunes N de S, Souto EX, Perobelli L de L, Simões BP, Guthy DA, Radimerski T, Castro FA de. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays [Internet]. Leukemia & Lymphoma. 2020 ; 61( 13): 3052-3065.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1080/10428194.2020.1805110
Artigo de periodico
Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia (2020)
Arcuri, Leonardo Javier; Nabhan, Samir Kanaan; Cunha, Renato Luiz Guerino; Nichele, Samantha; Ribeiro, Andreza Alice Feitosa; Fernandes, Juliana Folloni; Daudt, Liane Esteves; Rodrigues, Ana Luiza Melo; Arrais-Rodrigues, Celso; Seber, Adriana; Simões, Belinda Pinto
Fonte: Biology of Blood and Marrow Transplantation. Unidade: FMRP
Assuntos: CÉLULAS-TRONCO, ANEMIA, DOADORES DE SANGUE, HEMATOLOGIA, TRANSPLANTE DE MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARCURI, Leonardo Javier et al. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia. Biology of Blood and Marrow Transplantation, v. 26, n. 12, p. 2311-2317, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbmt.2020.09.007. Acesso em: 30 jun. 2024.
APA
Arcuri, L. J., Nabhan, S. K., Cunha, R. L. G., Nichele, S., Ribeiro, A. A. F., Fernandes, J. F., et al. (2020). Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia. Biology of Blood and Marrow Transplantation, 26( 12), 2311-2317. doi:10.1016/j.bbmt.2020.09.007
NLM
Arcuri LJ, Nabhan SK, Cunha RLG, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Simões BP. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 12): 2311-2317.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.bbmt.2020.09.007
Vancouver
Arcuri LJ, Nabhan SK, Cunha RLG, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Simões BP. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 12): 2311-2317.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.bbmt.2020.09.007
Artigo de periodico
Brazilian nutritional consensus in hematopoietic stem cell transplantation: adults (2020)
Barban, Juliana Bernardo; Simões, Belinda Pinto ; Moraes, Bruna Del Guerra de Carvalho; Anunciação, Cássia Rehem da; Rocha, Cristiane Santos da; Pintor, Daniela Cristina Querino; Guerra, Daiane Cristina; Silva, Deise Andrade; Brandão, Edith de Castro Martins; Kerbauy, Fábio; Pires, Fernanda Ramos de Oliveira; Morais, Graciele Lima; Schmidt-Filho, Jayr; Sicchieri, Juliana Maria Faccioli ; Barroso, Karine Sampaio Nunes; Viana, Luciana Verçoza; Rocha, Mariana Hollanda Martins da; Guimarães, Maysa Penteado; Lazzari, Natalia Leonetti Couto; Hamerschlak, Nelson; Ramos, Patricia; Gomes, Plinio Nascimento; Mendonça, Priscila da Silva; Oliveira, Raquel Candido de; Scomparim, Renata Corrêa; Chiattone, Ricardo; Diez Garcia, Rosa Wanda; Cardenas, Thaís de Campos; Miola, Thais Manfrinato; Costa, Thalita Cristina de Mello; Rocha, Vanderson Geraldo ; Pereira, Andrea Z.
Fonte: Einstein. Unidades: FMRP, FM
Assuntos: ANTROPOMETRIA, CÉLULAS-TRONCO, AVALIAÇÃO NUTRICIONAL, TERAPIA NUTRICIONAL, ESTADO NUTRICIONAL, NUTRIÇÃO PARENTERAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBAN, Juliana Bernardo et al. Brazilian nutritional consensus in hematopoietic stem cell transplantation: adults. Einstein, v. 18, p. 1-50, 2020Tradução . . Disponível em: https://doi.org/10.31744/einstein_journal/2020AE4530. Acesso em: 30 jun. 2024.
APA
Barban, J. B., Simões, B. P., Moraes, B. D. G. de C., Anunciação, C. R. da, Rocha, C. S. da, Pintor, D. C. Q., et al. (2020). Brazilian nutritional consensus in hematopoietic stem cell transplantation: adults. Einstein, 18, 1-50. doi:10.31744/einstein_journal/2020AE4530
NLM
Barban JB, Simões BP, Moraes BDG de C, Anunciação CR da, Rocha CS da, Pintor DCQ, Guerra DC, Silva DA, Brandão E de CM, Kerbauy F, Pires FR de O, Morais GL, Schmidt-Filho J, Sicchieri JMF, Barroso KSN, Viana LV, Rocha MHM da, Guimarães MP, Lazzari NLC, Hamerschlak N, Ramos P, Gomes PN, Mendonça P da S, Oliveira RC de, Scomparim RC, Chiattone R, Diez Garcia RW, Cardenas T de C, Miola TM, Costa TC de M, Rocha VG, Pereira AZ. Brazilian nutritional consensus in hematopoietic stem cell transplantation: adults [Internet]. Einstein. 2020 ; 18 1-50.[citado 2024 jun. 30 ] Available from: https://doi.org/10.31744/einstein_journal/2020AE4530
Vancouver
Barban JB, Simões BP, Moraes BDG de C, Anunciação CR da, Rocha CS da, Pintor DCQ, Guerra DC, Silva DA, Brandão E de CM, Kerbauy F, Pires FR de O, Morais GL, Schmidt-Filho J, Sicchieri JMF, Barroso KSN, Viana LV, Rocha MHM da, Guimarães MP, Lazzari NLC, Hamerschlak N, Ramos P, Gomes PN, Mendonça P da S, Oliveira RC de, Scomparim RC, Chiattone R, Diez Garcia RW, Cardenas T de C, Miola TM, Costa TC de M, Rocha VG, Pereira AZ. Brazilian nutritional consensus in hematopoietic stem cell transplantation: adults [Internet]. Einstein. 2020 ; 18 1-50.[citado 2024 jun. 30 ] Available from: https://doi.org/10.31744/einstein_journal/2020AE4530
Artigo de periodico
Differential cytokine network profile in polycythemia vera and secondary polycythemia (2020)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Coelho, Maria Gabriela Berzoti; Tognon, Raquel; Nunes, Natália de Souza ; Simões, Belinda Pinto ; Pereira, Ítalo Sousa; Sartori, Daniela Carlos ; Faccioli, Lucia Helena ; Pontes, Lorena Lobo de Figueiredo ; Frantz, Fabiani Gai ; Castro, Fabíola Attié de
Fonte: Scientific Reports. Unidades: FMRP, FCFRP
Assuntos: INTERLEUCINAS, TRANSTORNOS MIELOPROLIFERATIVOS, FISIOPATOLOGIA, CITOCINAS, NEOPLASIAS, MORTALIDADE, TROMBOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Differential cytokine network profile in polycythemia vera and secondary polycythemia. Scientific Reports, v. 10, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-63680-7. Acesso em: 30 jun. 2024.
APA
Cacemiro, M. da C., Cominal, J. G., Coelho, M. G. B., Tognon, R., Nunes, N. de S., Simões, B. P., et al. (2020). Differential cytokine network profile in polycythemia vera and secondary polycythemia. Scientific Reports, 10, 1-7. doi:10.1038/s41598-020-63680-7
NLM
Cacemiro M da C, Cominal JG, Coelho MGB, Tognon R, Nunes N de S, Simões BP, Pereira ÍS, Sartori DC, Faccioli LH, Pontes LL de F, Frantz FG, Castro FA de. Differential cytokine network profile in polycythemia vera and secondary polycythemia [Internet]. Scientific Reports. 2020 ; 10 1-7.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1038/s41598-020-63680-7
Vancouver
Cacemiro M da C, Cominal JG, Coelho MGB, Tognon R, Nunes N de S, Simões BP, Pereira ÍS, Sartori DC, Faccioli LH, Pontes LL de F, Frantz FG, Castro FA de. Differential cytokine network profile in polycythemia vera and secondary polycythemia [Internet]. Scientific Reports. 2020 ; 10 1-7.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1038/s41598-020-63680-7
Artigo de periodico-carta/editorial
Mobilisation and harvesting of haematopoietic progenitor cell in autoimmune diseases. [Carta] (2020)
De Santis, Gil Cunha; Dotoli, Giuliana Martinelli; Prado Júnior, Benedito Pina de Almeida; Moraes, Daniela Aparecida de; Dias, Juliana Bernardes Elias; Simões, Belinda Pinto ; Covas, Dimas Tadeu ; Oliveira, Maria Carolina
Fonte: Transfusion and Apheresis Science. Unidade: FMRP
Assuntos: HEMATOLOGIA, TRANSFUSÃO DE SANGUE, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE SANTIS, Gil Cunha et al. Mobilisation and harvesting of haematopoietic progenitor cell in autoimmune diseases. [Carta]. Transfusion and Apheresis Science. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.transci.2019.102680. Acesso em: 30 jun. 2024. , 2020
APA
De Santis, G. C., Dotoli, G. M., Prado Júnior, B. P. de A., Moraes, D. A. de, Dias, J. B. E., Simões, B. P., et al. (2020). Mobilisation and harvesting of haematopoietic progenitor cell in autoimmune diseases. [Carta]. Transfusion and Apheresis Science. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.transci.2019.102680
NLM
De Santis GC, Dotoli GM, Prado Júnior BP de A, Moraes DA de, Dias JBE, Simões BP, Covas DT, Oliveira MC. Mobilisation and harvesting of haematopoietic progenitor cell in autoimmune diseases. [Carta] [Internet]. Transfusion and Apheresis Science. 2020 ; 59( 2):[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.transci.2019.102680
Vancouver
De Santis GC, Dotoli GM, Prado Júnior BP de A, Moraes DA de, Dias JBE, Simões BP, Covas DT, Oliveira MC. Mobilisation and harvesting of haematopoietic progenitor cell in autoimmune diseases. [Carta] [Internet]. Transfusion and Apheresis Science. 2020 ; 59( 2):[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.transci.2019.102680
Artigo de periodico
HLA-matched unrelated donors for patients with sickle cell disease: results of international donor searches (2020)
Tozatto-Maio, Karina; Torres, Margareth Afonso; Deghaide, Neifi Hassan Saloum; Cardoso, Juliana Fernandes; Volt, Fernanda; Pinto, Ana Cristina Silva; Oliveira, Danielli; Elayoubi, Hanadi; Kashima, Simone; Loiseau, Pascale; Veelken, Hendrik; Ferster, Alina; Cappelli, Barbara; Rodrigues, Evandra Strazza; Scigliuolo, Graziana Maria; Kenzey, Chantal; Ruggeri, Annalisa; Rocha, Vanderson Geraldo ; Simões, Belinda Pinto ; Tamouza, Ryad; Gluckman, Eliane
Fonte: Biology of Blood and Marrow Transplantation. Unidades: FMRP, FM
Assuntos: DOADORES DE SANGUE, TRANSFUSÃO DE SANGUE, ANEMIA FALCIFORME, ANTÍGENOS DE HISTOCOMPATIBILIDADE, DOENÇAS HEMATOLÓGICAS, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO-MAIO, Karina et al. HLA-matched unrelated donors for patients with sickle cell disease: results of international donor searches. Biology of Blood and Marrow Transplantation, v. 26, n. 11, p. 2034-2039, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbmt.2020.07.015. Acesso em: 30 jun. 2024.
APA
Tozatto-Maio, K., Torres, M. A., Deghaide, N. H. S., Cardoso, J. F., Volt, F., Pinto, A. C. S., et al. (2020). HLA-matched unrelated donors for patients with sickle cell disease: results of international donor searches. Biology of Blood and Marrow Transplantation, 26( 11), 2034-2039. doi:10.1016/j.bbmt.2020.07.015
NLM
Tozatto-Maio K, Torres MA, Deghaide NHS, Cardoso JF, Volt F, Pinto ACS, Oliveira D, Elayoubi H, Kashima S, Loiseau P, Veelken H, Ferster A, Cappelli B, Rodrigues ES, Scigliuolo GM, Kenzey C, Ruggeri A, Rocha VG, Simões BP, Tamouza R, Gluckman E. HLA-matched unrelated donors for patients with sickle cell disease: results of international donor searches [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 11): 2034-2039.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.015
Vancouver
Tozatto-Maio K, Torres MA, Deghaide NHS, Cardoso JF, Volt F, Pinto ACS, Oliveira D, Elayoubi H, Kashima S, Loiseau P, Veelken H, Ferster A, Cappelli B, Rodrigues ES, Scigliuolo GM, Kenzey C, Ruggeri A, Rocha VG, Simões BP, Tamouza R, Gluckman E. HLA-matched unrelated donors for patients with sickle cell disease: results of international donor searches [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 11): 2034-2039.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.015
Trabalho de evento-resumo periodico
Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) (2020)
Kassim, Adetola A.; de la Fuente, Josu; Alahmari, Ali Debsan; Eckrich, Michael J.; Hanna, Rabi; Dhedin, Nathalie; Horn, Biljana N.; Black, Vandy; Gouveia, Roseane V.; Seber, Adriana; Simões, Belinda Pinto ; Costa, Thalita Cristina de Mello; Cunha, Renato Luiz Guerino
Fonte: Blood. Nome do evento: ASH Annual Meeting and Exposition. Unidade: FMRP
Assuntos: TRANSPLANTE DE MEDULA ÓSSEA, HEMATOLOGIA, ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KASSIM, Adetola A. et al. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-141771. Acesso em: 30 jun. 2024. , 2020
APA
Kassim, A. A., de la Fuente, J., Alahmari, A. D., Eckrich, M. J., Hanna, R., Dhedin, N., et al. (2020). Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-141771
NLM
Kassim AA, de la Fuente J, Alahmari AD, Eckrich MJ, Hanna R, Dhedin N, Horn BN, Black V, Gouveia RV, Seber A, Simões BP, Costa TC de M, Cunha RLG. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) [Internet]. Blood. 2020 ; 136 5 .[citado 2024 jun. 30 ] Available from: https://doi.org/10.1182/blood-2020-141771
Vancouver
Kassim AA, de la Fuente J, Alahmari AD, Eckrich MJ, Hanna R, Dhedin N, Horn BN, Black V, Gouveia RV, Seber A, Simões BP, Costa TC de M, Cunha RLG. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) [Internet]. Blood. 2020 ; 136 5 .[citado 2024 jun. 30 ] Available from: https://doi.org/10.1182/blood-2020-141771

Unidades USP

ReP

Filtros

Tipo de material

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos